Beyond Weight Loss
GLP-1s Do More Than You Think
Research shows GLP-1 medications help with inflammation, heart health, liver disease, joint pain, and more. Here's what the science says — and how to access them affordably.
What the Research Shows
20% fewer heart attacks
FDA-approved cardiovascular benefit
3.1 years younger
Biological age reduction on semaglutide
40% lower inflammation
CRP reduction in major trials
Research-Backed Guides
Condition-Specific GLP-1 Guides
Each guide breaks down the research, honest limitations, and affordable access options
GLP-1s & Heart Health
FDA-approved for cardiovascular risk — 20% reduction in heart attacks
FDA-Approved
GLP-1s & Sleep Apnea
FDA-approved — may reduce or replace CPAP for some patients
FDA-Approved
GLP-1s & Fatty Liver
FDA-approved for MASH — how GLP-1s reduce liver fat and fibrosis
FDA-Approved
GLP-1s & Kidney Disease
FDA-approved for diabetic CKD — slowing progression to dialysis
FDA-Approved
GLP-1s & Addiction
Semaglutide reduces alcohol cravings — Lancet 2026 RCT data
RCT Data
GLP-1s & Alzheimer's
40-70% lower risk in observational studies — prevention vs. treatment
Emerging
GLP-1s & Aging
New study: biological age reduced by 3.1 years on semaglutide
New Research
GLP-1s & Type 2 Diabetes
HbA1c reduced 1.5-2.0%, cardiovascular death cut 26% — the foundational use case
FDA-Approved
GLP-1s & Prediabetes
Semaglutide and tirzepatide reversed prediabetes in 80-90% of trial participants
GLP-1s & Insulin Resistance
HOMA-IR falls 30-50% in trials — treating the root cause of weight gain
GLP-1s & Stroke
39% reduction in non-fatal stroke in SUSTAIN 6 — plus cardiovascular protection
RCT Data
GLP-1s & Blood Pressure
3-8 mmHg systolic reduction in major trials — meaningful heart and kidney protection
GLP-1s & Cholesterol
Triglycerides down 15-20%, inflammation down ~40% — but not a statin replacement
GLP-1s & Neuropathy
86% showed nerve improvement within 1 month — potential reversal of nerve damage
Emerging
GLP-1s & Gout
Weight loss lowers uric acid — cohort data show fewer flares in GLP-1 users
GLP-1s & Lupus
Anti-inflammatory effects, prednisone weight gain, safety with immunosuppressants
GLP-1s & Arthritis
Joint pain relief from both weight loss and direct anti-inflammatory effects
GLP-1s & Parkinson's
40-60% lower risk in observational studies — neuroprotection via GLP-1 brain receptors
Emerging
GLP-1s & Mental Health
Depression, anxiety, and neuroprotective effects — what the research says
GLP-1s & Binge Eating
GLP-1s suppress food-reward dopamine signaling — binge episodes reduced 40-70%
Emerging
GLP-1s & PCOS
Insulin resistance, hormone balance, and fertility considerations
GLP-1s & Fertility
"Ozempic babies," PCOS ovulation, and when to stop before pregnancy
GLP-1s & Sexual Health
Libido, ED, and peptide options that work alongside GLP-1 therapy
GLP-1s & Cancer Risk
17-41% lower cancer risk in large studies — what it means and doesn't prove
Emerging
GLP-1s & Bone Health
No fracture increase in 17,600+ patients — bone-protective despite weight loss
GLP-1s & Psoriasis
Skin inflammation, TNF-alpha reduction, and biologic interactions
GLP-1s & IBD
Crohn's, ulcerative colitis — fewer hospitalizations, no flare signal
GLP-1s & Migraines
Migraine days cut nearly in half — independent of weight loss
GLP-1s & Menopause
HRT + GLP-1 synergy, visceral fat, and bone density considerations
GLP-1s & Asthma/COPD
14-18% lower respiratory disease risk — airway inflammation reduction
The Science
Why GLP-1s Help With More Than Weight
How GLP-1s work beyond appetite
GLP-1 receptor agonists (like Ozempic, Wegovy, and Zepbound) do more than reduce appetite. They suppress inflammatory pathways (NF-kB), reduce cytokines (TNF-alpha, IL-6), protect kidneys, and have neuroprotective effects. These mechanisms help explain why GLP-1s show benefits for autoimmune conditions, liver disease, sleep apnea, joint pain, and mental health.
The access problem
- ✕ Insurance rarely covers GLP-1s for conditions beyond diabetes and obesity
- ✕ Most doctors don't know about the off-label benefits
- ✕ Brand-name prices are $1,000+/month without coverage
That's why this site exists. We break down the research and show you how to access GLP-1s affordably through telehealth.
Compare Providers
Telehealth GLP-1 Providers Compared
All platforms prescribe compounded semaglutide with licensed providers, no insurance required
| Provider | Price | Includes | Best For | |
|---|---|---|---|---|
| Oak Loves You Top Pick | $133/mo |
| Best overall value with coaching support | Visit Oak |
| Gala Lowest Price | $129/mo |
| Budget-conscious — lowest monthly cost | Visit Gala |
| ShedRx Money-Back Guarantee | $159/mo |
| Risk-free trial with coaching support | Visit ShedRx |
| YourEra Health | $99/mo |
| Physician-led, fast fulfillment | Visit YourEra |
Independent & Research-Backed
This site isn't run by a telehealth company. Every article cites published research.
Cites Real Studies
We reference specific trials, cohort studies, and systematic reviews — not marketing claims.
Honest Limitations
Every guide covers what GLP-1s can't do, not just what they can. No hype, no miracle claims.
Ready to explore your options?
Start with a condition guide to understand the research, or compare telehealth providers to find the right fit for your situation and budget.
Questions? contact@glp1forwellness.com